Yi Larson
Director/Board Member chez OLEMA PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Provenance du réseau au premier degré de Yi Larson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Biotechnology | 20 | |
13
| Subsidiary | Pharmaceuticals: Major | 13 |
7
| Public Company | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yi Larson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Director/Board Member Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | General Counsel Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member President | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| California Polytechnic State University (San Luis Obispo) | College/University | Undergraduate Degree Undergraduate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member President | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| METACRINE, INC. | Biotechnology | Founder Chief Executive Officer Chief Operating Officer | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder Chief Operating Officer | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| VENTYX BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chief Executive Officer Chairman | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
Ceptur Therapeutics, Inc.
 Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Masters Business Admin | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| University of Pennsylvania Medical Center | College/University | Graduate Degree Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 48 |
| Royaume-Uni | 3 |
| Irlande | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 16 |
| Finance | 4 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 306 |
| Corporate Officer/Principal | 133 |
| Independent Dir/Board Member | 124 |
| Undergraduate Degree | 52 |
| Chief Tech/Sci/R&D Officer | 36 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Ian Clark | 35 |
| Richard Heyman | 33 |
| Maha Katabi | 28 |
| Andy Rappaport | 27 |
| Debra Yu | 21 |
| Aaron Royston | 19 |
| Aaron Kantoff | 19 |
| Pamela Klein | 19 |
| Jacob Chacko | 18 |
| Sheila Gujrathi | 18 |
| Cynthia Butitta | 16 |
| Barbara Bodem | 16 |
| Angie You | 15 |
| Garry Nicholson | 14 |
